Recently, Szotet al. demonstrated the potential of delivering antibody drug conjugates targeting TEM8 to tumor-associated stromal cells, thereby unexpectedly but effectively killing nearby cancer cells67. This evidence concerns the gene ANTXR1 and neoplasm.